JP7699539B2 - 多量体タンパク質の形成を阻害するバインダー - Google Patents
多量体タンパク質の形成を阻害するバインダー Download PDFInfo
- Publication number
- JP7699539B2 JP7699539B2 JP2021518942A JP2021518942A JP7699539B2 JP 7699539 B2 JP7699539 B2 JP 7699539B2 JP 2021518942 A JP2021518942 A JP 2021518942A JP 2021518942 A JP2021518942 A JP 2021518942A JP 7699539 B2 JP7699539 B2 JP 7699539B2
- Authority
- JP
- Japan
- Prior art keywords
- protein
- polypeptide
- variant
- tnf
- binding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1086—Preparation or screening of expression libraries, e.g. reporter assays
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2318/00—Antibody mimetics or scaffolds
- C07K2318/20—Antigen-binding scaffold molecules wherein the scaffold is not an immunoglobulin variable region or antibody mimetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Crystallography & Structural Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Plant Pathology (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- Toxicology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025064215A JP2025108528A (ja) | 2018-10-07 | 2025-04-09 | 多量体タンパク質の形成を阻害するバインダー |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18306324.7A EP3632924A1 (en) | 2018-10-07 | 2018-10-07 | Binders for inhibiting formation of multimeric proteins |
| EP18306324.7 | 2018-10-07 | ||
| PCT/EP2019/076986 WO2020074402A1 (en) | 2018-10-07 | 2019-10-06 | Binders for inhibiting formation of multimeric proteins |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025064215A Division JP2025108528A (ja) | 2018-10-07 | 2025-04-09 | 多量体タンパク質の形成を阻害するバインダー |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022501063A JP2022501063A (ja) | 2022-01-06 |
| JP2022501063A5 JP2022501063A5 (cg-RX-API-DMAC7.html) | 2022-10-07 |
| JP7699539B2 true JP7699539B2 (ja) | 2025-06-27 |
Family
ID=64017330
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021518942A Active JP7699539B2 (ja) | 2018-10-07 | 2019-10-06 | 多量体タンパク質の形成を阻害するバインダー |
| JP2025064215A Pending JP2025108528A (ja) | 2018-10-07 | 2025-04-09 | 多量体タンパク質の形成を阻害するバインダー |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025064215A Pending JP2025108528A (ja) | 2018-10-07 | 2025-04-09 | 多量体タンパク質の形成を阻害するバインダー |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20210380647A1 (cg-RX-API-DMAC7.html) |
| EP (2) | EP3632924A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7699539B2 (cg-RX-API-DMAC7.html) |
| ES (1) | ES3068042T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020074402A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3004650B1 (fr) * | 2013-04-22 | 2015-05-29 | Affilogic | Composition topique comprenant un variant d'une protéine sauvage à pli-OB, ainsi que son procédé de préparation |
| EP4043481A1 (en) | 2021-02-15 | 2022-08-17 | Affilogic | Compounds and methods for extending half life of biomolecules |
| EP4190358A1 (en) | 2021-12-05 | 2023-06-07 | Affilogic | Polypeptide as carrier for intestinal barrier crossing |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010511691A (ja) | 2006-12-04 | 2010-04-15 | インスティティ・パスツール | 新たな特異的結合体を工学的に操作するための足場として使用されるob−フォールド |
| WO2017161096A1 (en) | 2016-03-16 | 2017-09-21 | Tarveda Therapeutics, Inc. | Antibody mimic conjugates and particles |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007011891A2 (en) * | 2005-07-15 | 2007-01-25 | Strategene California | Dna binding protein-polymerase chimeras |
| ZA200810836B (en) | 2006-05-26 | 2010-07-28 | Obodies Ltd | OB fold domains |
| FR2974816A1 (fr) | 2011-05-04 | 2012-11-09 | Centre Nat Rech Scient | Methode de generation de proteines |
| FR3004650B1 (fr) | 2013-04-22 | 2015-05-29 | Affilogic | Composition topique comprenant un variant d'une protéine sauvage à pli-OB, ainsi que son procédé de préparation |
| FR3027521B1 (fr) | 2014-10-24 | 2016-12-16 | Affilogic | Compositions pour administration par voie orale |
| EP3483180A1 (en) * | 2017-11-14 | 2019-05-15 | Affilogic | Multi specific molecules |
-
2018
- 2018-10-07 EP EP18306324.7A patent/EP3632924A1/en not_active Ceased
-
2019
- 2019-10-06 EP EP19779920.8A patent/EP3861011B1/en active Active
- 2019-10-06 JP JP2021518942A patent/JP7699539B2/ja active Active
- 2019-10-06 WO PCT/EP2019/076986 patent/WO2020074402A1/en not_active Ceased
- 2019-10-06 US US17/283,369 patent/US20210380647A1/en active Pending
- 2019-10-06 ES ES19779920T patent/ES3068042T3/es active Active
-
2025
- 2025-04-09 JP JP2025064215A patent/JP2025108528A/ja active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010511691A (ja) | 2006-12-04 | 2010-04-15 | インスティティ・パスツール | 新たな特異的結合体を工学的に操作するための足場として使用されるob−フォールド |
| WO2017161096A1 (en) | 2016-03-16 | 2017-09-21 | Tarveda Therapeutics, Inc. | Antibody mimic conjugates and particles |
Non-Patent Citations (2)
| Title |
|---|
| Biotechnology and Bioengineering,Vol.114, No.3,pp.481-491 |
| PLoS ONE,2010年,Vol.5, No.5, e10728,pp.1-10 |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2022501063A (ja) | 2022-01-06 |
| JP2025108528A (ja) | 2025-07-23 |
| EP3861011B1 (en) | 2026-02-11 |
| WO2020074402A1 (en) | 2020-04-16 |
| EP3861011A1 (en) | 2021-08-11 |
| ES3068042T3 (es) | 2026-05-27 |
| EP3861011C0 (en) | 2026-02-11 |
| US20210380647A1 (en) | 2021-12-09 |
| EP3632924A1 (en) | 2020-04-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025108528A (ja) | 多量体タンパク質の形成を阻害するバインダー | |
| AU2007330409B2 (en) | OB-fold used as scaffold for engineering new specific binders | |
| Ubah et al. | Novel, anti-hTNF-α variable new antigen receptor formats with enhanced neutralizing potency and multifunctionality, generated for therapeutic development | |
| JP2019501885A (ja) | 多特異性抗体 | |
| KR101740030B1 (ko) | ScFv 항체 라이브러리, 이의 제조방법 및 이를 이용한 ScFv 항체 스크리닝 방법 | |
| JP2019501887A (ja) | 多特異性抗体 | |
| Wang et al. | Construction of a single chain variable fragment antibody (scFv) against tetrodotoxin (TTX) and its interaction with TTX | |
| Angelini et al. | Directed evolution of broadly crossreactive chemokine-blocking antibodies efficacious in arthritis | |
| CN114380906B (zh) | 一种抗il-17a的单域抗体及其用途 | |
| Sun et al. | Improvement in affinity and thermostability of a fully human antibody against interleukin-17A by yeast-display technology and CDR grafting | |
| US20230120167A1 (en) | Variants of sac7d and their use in cancer therapy | |
| US20240124531A1 (en) | Compounds and methods for extending half life of biomolecules | |
| CN114555633A (zh) | 用于靶向扩增免疫效应细胞的方法和材料 | |
| CN116829584A (zh) | 一种抗pd-1的单域抗体 | |
| KR101482237B1 (ko) | 항 il-6r 및 tnfr2을 포함하는 이중특이적 단백질을 발현하는 미니서클 벡터를 포함하는 자가 면역 질환 치료용 약학 조성물 | |
| CN111909268B (zh) | 低免疫原性低ADCC/CDC功能抗TNF-α人源化单克隆抗体TCX060及其应用 | |
| EP4059949A1 (en) | Anti-factor c3 sac7d variants and their medical use for treating complement-mediated disorders | |
| Dong et al. | The Protective Antibodies Induced by a Novel Epitope of Human TNF-α Could Suppress the Development of Collagen-Induced Arthritis | |
| US20260116924A1 (en) | Polypeptide as carrier for intestinal barrier crossing | |
| Xu et al. | Surrobodies with functional tails | |
| Geng et al. | Screening and Characterization of EGFR-Targeted Specific Nanobodies | |
| CN117597353A (zh) | 抗因子c3的sac7d变体及其治疗补体介导疾患的医疗用途 | |
| HK1117548B (en) | Ob-fold used as scaffold for engineering new specific binders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220929 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220929 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230719 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20231017 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20231215 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240112 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20240318 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20240405 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20240614 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240909 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20241216 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250409 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20250409 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20250526 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20250617 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7699539 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |